Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.32 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.32 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL150601 | 0.97 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL8985021 | 0.97 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL8386961 | 0.97 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL8985028 | 0.97 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL673528 | 0.97 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL672963 | 0.97 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| Hydrochloric Acid SCHEMBL4680206 | 0.97 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL638833 | 0.97 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| Hydrazine SCHEMBL16039959 | 0.94 | TP53 (0.35) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| Cyclohexane SCHEMBL3905056 | 0.91 | ADH1B (0.34) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 294 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2903979-B1 | NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES | INHIBIKASE THERAPEUTICS INC (US) | 2020-08-19 | — | — | EP | claimed |
| EP-2945960-A2 | ABIRATERONE AND ANALOGS THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CORTISOL OVERPRODUCTION | Cortendo AB (publ) (US) | 2015-11-25 | — | — | EP | claimed |
| WO-2014111815-A2 | ABIRATERONE AND ANALOGS THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CORTISOL OVERPRODUCTION | CORTENDO AB (PUBL) (US) | 2014-07-24 | — | — | WO | claimed |
| EP-2693876-A1 | SUBSTITUTED METHYLFORMYL REAGENTS AND METHOD OF USING SAME TO MODIFY PHYSICOCHEMICAL AND/OR PHARMACOKINETIC PROPERTIES OF COMPOUNDS | Sphaera Pharma Pte. Ltd (SG) | 2014-02-12 | — | — | EP | claimed |
| WO-2012137225-A1 | SUBSTITUTED METHYLFORMYL REAGENTS AND METHOD OF USING SAME TO MODIFY PHYSICOCHEMICAL AND/OR PHARMACOKINETIC PROPERTIES OF COMPOUNDS | SPHAERA PHARMA PVT. LTD (IN) | 2012-10-11 | — | — | WO | claimed |
| JP-4795589-B2 | — | — | 2011-10-19 | — | — | JP | claimed |
| EP-1747201-B1 | 2H OR 3H-BENZO[E]INDAZOL-1-YLE CARBAMATE DERIVATIVES, THE PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI AVENTIS (FR) | 2008-10-15 | — | — | EP | claimed |
| EP-1272500-B1 | PROCESS FOR PREPARING 6-O-ALKENYL-SUBSITUTED ERYTHROMYCIN DERIVATIVES | ABBOTT LAB (US) | 2005-05-04 | — | — | EP | claimed |
| EP-1272500-A2 | PROCESS FOR PREPARING 6-O-ALKENYL-SUBSITUTED ERYTHROMYCIN DERIVATIVES | Abbott Laboratories (US) | 2003-01-08 | — | — | EP | claimed |
| WO-2000078773-A2 | PROCESS FOR PREPARING 6-O-ALKENYL-SUBSTITUTED ERYTHROMYCIN DERIV ATIVES | ABBOTT LABORATORIES (US) | 2000-12-28 | — | — | WO | claimed |
| EP-0238883-B1 | OXABICYCLOHEPTANE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND USE | SUNTORY LIMITED (JP) | 1990-05-09 | — | — | EP | claimed |
| US-4713453-A | TREATMENT OF BRAIN DISORDERS | Suntori Limited (JP) | 1987-12-15 | — | — | US | claimed |
| EP-0238883-A1 | Oxabicycloheptane derivatives, pharmaceutical composition and use | SUNTORY LIMITED (JP) | 1987-09-30 | — | — | EP | claimed |
| US-20240228449-A1 | METHOD FOR PREPARING TERTIARY AMINE WITH SECONDARY AMINE AS RAW MATERIAL | ZHEJIANG XINHUA CHEMICAL CO., LTD (CN) | 2024-07-11 | — | — | US | disclosed |
| US-20240166603-A1 | Method of Treating Cancer With Atpenin A5 Derviatives | UNIV TEXAS TECH SYSTEM (US) | 2024-05-23 | — | — | US | disclosed |
| CN-114615999-B | Drug antibody conjugates | 法马马有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-4851291-A | Temperature adaptable textile fibers and method of preparing same | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1989-07-25 | — | — | US | disclosed |
| EP-0311642-A1 | TEMPERATURE ADAPTABLE TEXTILE FIBERS AND METHOD OF PREPARING SAME. | US COMMERCE (US) | 1989-04-19 | — | — | EP | disclosed |
| WO-1987007854-A1 | TEMPERATURE ADAPTABLE TEXTILE FIBERS AND METHOD OF PREPARING SAME | UNITED STATES OF AMERICA, REPRESENTED BY THE SECRE (US) | 1987-12-30 | — | — | WO | disclosed |
| EP-0188383-A2 | Imidazole derivatives, their preparation and therapeutic use | SANKYO COMPANY LIMITED (JP) | 1986-07-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228449-A1 | METHOD FOR PREPARING TERTIARY AMINE WITH SECONDARY AMINE AS RAW MATERIAL | OTC, AOC1, ODC1 | TP53 2223/4885P2RX4 1768/4885P2RX1 1290/4885 |
| US-20240166603-A1 | Method of Treating Cancer With Atpenin A5 Derviatives | ATP5MG, ATP5ME, ATP5MK | TP53 75/4885P2RX4 346/4885P2RX1 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.